ADIA Med verifies 361 round-lot holders for Nasdaq Capital Market listing test
Nasdaq’s initial listing requirement for the Nasdaq Capital Market includes a distribution test with sufficiently broad public shareholder base. ADIA Med verified it has 361 round-lot holders.